Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2026 Earnings Call Transcript May 14, 2026
Operator: Hello. Thank you for standing by, and welcome to Therapeutics First Quarter 26 Conference Call. After the speakers’ presentation, there will be a question and answer session. Telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be aware that today’s conference call is being recorded. I would now like to...
